Tissue and Pathology/Immunology Core
Tissue and Pathology/Immunology Core
批准号:
9792858
负责人:
LAWRENCE S LAMB
金额:
$12.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AlabamaAntigensBioinformaticsBiologicalBiological AssayBiometryBlindedBloodBlood BanksBlood specimenCarcinomaClinicalClinical ProtocolsClinical TrialsColoradoConsultationsCountryCytologyData SetDatabasesDevelopmentDisastersDiseaseDoctor of MedicineDoctor of PhilosophyDysplasiaEnrollmentEnsureFundingGenerationsGenotypeGoalsGuidelinesGynecologicGynecologyHarvestHistologicHumanHuman Papilloma Virus VaccineHuman PapillomavirusHuman ResourcesImage AnalysisImmune responseImmunologicsImmunologyIn SituInstitutionLesionLiquid substanceMalignant neoplasm of cervix uteriMicrodissectionMicroscopicMolecularMolecular AnalysisNational Cancer InstituteNational Research CouncilNormal tissue morphologyOnline SystemsPathologicPathologistPathologyPatient CarePatientsPeripheral Blood Mononuclear CellPhotographyPractice GuidelinesProcessProtocols documentationRecommendationRecoveryReproducibilityResearchResearch DesignResearch PersonnelResource SharingResourcesSamplingSerologicalSerumShipsSiteSpecimenSupervisionSystemT-LymphocyteTissue BanksTissue MicroarrayTissue SampleTissue StainsTissuesTranslational ResearchUniversitiesVaccinationValidationWorkWorld Health Organizationbasebiobankcareerclinically relevantdata integritydata managementdigitaldigital imagingencryptionhuman tissueimage processinglaser capture microdissectionmemberneoplasticpreservationprogramsrecruitsuccesstissue preparationtumor
中文摘要
项目摘要/摘要:
建立这一核心组织/病理学/免疫学基础设施的总体目标是完成收购、保存、储存和分发。
经临床注释的、高质量的人类生殖器生物标本与宫颈癌和HPV感染相关。
提供病理学和免疫学方面的专业知识、技术支持、检测和现场检测,以便为患者提供基于组织的检测。
调查人员在约翰霍普金斯大学、阿拉巴马州州立大学和阿拉巴马州州立大学进行了宫颈癌和孢子学研究。
伯明翰,华盛顿和科罗拉多州立大学博尔德分校,以及其他外部技术合作者。该核心项目一直没有投入使用。
自1998年以来,在子宫颈癌孢子学的支持下,我们的合作范围不断扩大。到目前为止,我们已经有了。
保存了来自4299名受试者的血液、细胞学检查和组织学样本,并支持了6项临床试验。包括所有的人类组织。
他们的生物体液是根据美国国家癌症研究所的全球最佳医疗实践进行收集和储存的。
《生物仓库指南》。已对核心生物仓库人员进行了全面扩展,以加强专家的病理诊断和诊断。
向调查人员提供免疫学咨询,包括为儿童的定量和数字图像分析提供指导。
多参数分子生物学研究组织的结构,包括显微解剖,组织微阵列的制备方法,以及HPV。
基因分型,HPV和血清流行病学检测,HPV抗原检测,特异性T淋巴细胞亚群(FEST)功能检测,通过TCR检测。
Vβ的克隆型包括测序和定量。组织、细胞学和血液标本的采集库由医生监督。
妇科病理学家和临床医生同事在妇科工作。我们的网站上登记了一些受试者的临床医学信息。
临床医学协议已经进入了一个受密码保护的基于网络的医疗跟踪系统。这是一个基于网络的内部医疗系统。
系统遵循美国国家互联网研究理事会的建议,包括用户身份验证。
加密、审计、跟踪、监控和灾难恢复。建立了一个全面的审查和机制,以确定文件分发的优先顺序。
要求提供资源,以帮助调查人员在内部和外部调查约翰霍普金斯大学和子宫颈癌患者的孢子。
生物样本也已经被分享给了来自全国各地的学术研究机构的合作者。
资源是确保所有四个基于HPV疫苗的芽胞疫苗项目最终成功的关键因素,我们将继续支持所有四个基于HPV的项目。
来自外部合作伙伴的基于疫苗的孢子研究项目,以及全球发展研究计划。
职业发展促进计划(DEP)包括获奖者、获奖者和外部合作伙伴。该计划的核心由博士领导。
安娜和耶梅利亚诺娃,医学博士(UAB),劳伦斯·兰姆,博士(UAB),拉斐尔·维西迪,医学博士(JHU),和罗素·冯,
医学博士(JHU)。联合调查人员表示,支持核心医学中心的人包括以下博士:Kellie和Smith博士,JHU博士,Sailesh博士和Pillai博士。
(UAB),罗伯特·安德斯(Robert Anders),医学博士,罗伯特·安德斯(Robert Anders,JHU)。
英文摘要
Project Summary/Abstract
The overall goal of this Tissue/Pathology/Immunology Core (Core C) is to acquire, preserve, and distribute
clinically-annotated, high-quality human biospecimens related to cervical cancer and HPV disease, and to
provide pathologic and immunologic expertise, support, and in situ analyses for tissue-based analyses for
investigators in the Cervical Cancer SPORE at the Johns Hopkins University, the University of Alabama at
Birmingham, and the University of Colorado at Boulder, as well as external collaborators. Core C has been in
existence since 1998, and has expanded with the support of the Cervical Cancer SPORE. To date, we have
banked blood, cytologic and tissue samples from 4299 subjects and supported 6 clinical trials. All human tissues
and biologic fluids are harvested and banked in accordance with the National Cancer Institute’s Best Practice
Guidelines for Biorepositories. Core C personnel have been expanded to strengthen expert pathologic and
immunologic consultation to investigators, including guidance for quantitative digital image analyses of
multiparameter molecular studies of tissues, microdissection, preparation of tissue microrarrays, HPV
genotyping, HPV seroepidemiology and HPV Antigen Functional Expansion of Specific T cells (FEST) via TCR
Vβ clonotype sequencing and quantitation. Collection of tissue, cytologic and blood specimens is supervised by
gynecologic pathologists and clinical colleagues in gynecology. Clinical information for subjects enrolled in our
clinical protocols is entered into a password-protected web-based tracking system. This internal web-based
system follows the recommendations of the National Research Council, and includes user authentication,
encryption, audit trails, and disaster recovery. A review mechanism is in place for prioritization of distribution of
requested resources to investigators within and external to the Johns Hopkins Cervical Cancer SPORE.
Biosamples have been shared with collaborators at academic institutions across the country. This shared
resource is pivotal to the success of all four HPV vaccine-based SPORE projects and will support all four HPV
vaccine-based SPORE projects external collaborators, as well as the Developmental Research Program
(DEP) and Career Enhancement Program (CEP) awardees, and external collaborators. Core C is led by Drs.
Anna Yemelyanova, M.D. (UAB), Lawrence Lamb, Ph.D. (UAB), Raphael Viscidi, M.D. (JHU), and Russell Vang,
M.D. (JHU). Co-Investigators that support Core C include Drs. Kellie Smith, Ph.D. (JHU), Sailesh Pillai, Ph.D.
(UAB), Deyin Xing, M.D., Ph.D. (JHU), and Robert Anders, M.D., Ph.D. (JHU).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Donor Innate Lymphocyte Infusion Product for Immunotherapy of Glioblastoma Multif
-
批准号:7772397
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2010
-
负责人:LAWRENCE S LAMB
-
依托单位:
Tissue/Pathology Core
-
批准号:7727558
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2009
-
负责人:LAWRENCE S LAMB
-
依托单位:
Feasibility of gamma/delta T cell immunotherapy for glioblastoma
-
批准号:7487823
-
项目类别:
-
资助金额:$15.86万
-
财政年份:2007
-
负责人:LAWRENCE S LAMB
-
依托单位:
Feasibility of gamma/delta T cell immunotherapy for glioblastoma
-
批准号:7313172
-
项目类别:
-
资助金额:$15.86万
-
财政年份:2007
-
负责人:LAWRENCE S LAMB
-
依托单位:
Feasibility of gamma/delta T cell immunotherapy for glioblastoma
-
批准号:7869514
-
项目类别:
-
资助金额:$7.12万
-
财政年份:2007
-
负责人:LAWRENCE S LAMB
-
依托单位:
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER: AIDS
-
批准号:7335103
-
项目类别:
-
资助金额:$5.24万
-
财政年份:2006
-
负责人:LAWRENCE S LAMB
-
依托单位:
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER: SICKLE CELL DISEASE, GENE THERAPY
-
批准号:7335105
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2006
-
负责人:LAWRENCE S LAMB
-
依托单位:
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER; IMMUNOLOGY, CELL BIOLOGY
-
批准号:7335107
-
项目类别:
-
资助金额:$5.24万
-
财政年份:2006
-
负责人:LAWRENCE S LAMB
-
依托单位:
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER: CANCER: MELANOMA, GLIOMA
-
批准号:7335104
-
项目类别:
-
资助金额:$3.49万
-
财政年份:2006
-
负责人:LAWRENCE S LAMB
-
依托单位:
BD Biosciences FACS Canto Flow Cytometer
-
批准号:7046224
-
项目类别:
-
资助金额:$17.46万
-
财政年份:2006
-
负责人:LAWRENCE S LAMB
-
依托单位:
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER: MOUSE STEM CELLS: ADULT & EMBRYONIC
-
批准号:7335106
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2006
-
负责人:LAWRENCE S LAMB
-
依托单位:
ANTILEUKEMIC EFFECT OF GAMMA/DELTA T CELLS
-
批准号:6041896
-
项目类别:
-
资助金额:$10.57万
-
财政年份:2000
-
负责人:LAWRENCE S LAMB
-
依托单位:
ANTILEUKEMIC EFFECT OF GAMMA/DELTA T CELLS
-
批准号:6350268
-
项目类别:
-
资助金额:$10.94万
-
财政年份:2000
-
负责人:LAWRENCE S LAMB
-
依托单位:
ANTILEUKEMIC EFFECT OF GAMMA/DELTA T CELLS
-
批准号:6433692
-
项目类别:
-
资助金额:$2.02万
-
财政年份:2000
-
负责人:LAWRENCE S LAMB
-
依托单位:
Tissue/Pathology Core
-
批准号:8182336
-
项目类别:
-
资助金额:$21.75万
-
财政年份:--
-
负责人:LAWRENCE S LAMB
-
依托单位:
Tissue/Pathology Core
-
批准号:8379255
-
项目类别:
-
资助金额:$23.27万
-
财政年份:--
-
负责人:LAWRENCE S LAMB
-
依托单位:
Tissue/Pathology Core
-
批准号:8326156
-
项目类别:
-
资助金额:$23.01万
-
财政年份:--
-
负责人:LAWRENCE S LAMB
-
依托单位:
Tissue/Pathology Core
-
批准号:8537835
-
项目类别:
-
资助金额:$22.76万
-
财政年份:--
-
负责人:LAWRENCE S LAMB
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: